Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnauld Verschuur

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Environmental Research|October 21, 2023
Residential proximity to vines and risk of childhood embryonal tumours in France - GEOCAP case-control study, 2006-2013Danielle Awounou, Matthieu Mancini, Brigitte Lacour, et al.
Archives of Toxicology|May 20, 2005
Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in ratsKirsten Schimmel, Roel Bennink, Kora de Bruin, et al.
Cancers|January 6, 2021
A Randomized Trial of Physical Activity in Children and Adolescents with CancerPaul Saultier, Clothilde Vallet, Frédéric Sotteau, et al.
Translational Oncology|August 2, 2011
Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric OncologyEddy Pasquier, Mark W Kieran, Jaroslav Sterba, et al.
Cancer Causes & Control : CCC|March 8, 2020
Maternal and perinatal characteristics, congenital malformations and the risk of wilms tumor: the ESTELLE studyHélène Bauer, Paula Rios, Gudrun Schleiermacher, et al.
Frontiers in Pharmacology|October 16, 2018
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical TrialArnauld Verschuur, Marie-Amélie Heng-Maillard, Philippe Dory-Lautrec, et al.
Pediatric Blood & Cancer|November 19, 2019
Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experienceCécile Picard, Cécile Faure-Conter, Pierre Leblond, et al.
Nature Communications|November 30, 2023
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumorsXiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, et al.
Pediatric Blood & Cancer|October 28, 2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study GroupJanna A Hol, Marry M van den Heuvel-Eibrink, Norbert Graf, et al.
The Lancet. Oncology|July 2, 2018
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol databaseJesper Brok, Marta Lopez-Yurda, Harm V Tinteren, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Environmental Research|October 21, 2023
Residential proximity to vines and risk of childhood embryonal tumours in France - GEOCAP case-control study, 2006-2013Danielle Awounou, Matthieu Mancini, Brigitte Lacour, et al.
Archives of Toxicology|May 20, 2005
Absence of cardiotoxicity of the experimental cytotoxic drug cyclopentenyl cytosine (CPEC) in ratsKirsten Schimmel, Roel Bennink, Kora de Bruin, et al.
Cancers|January 6, 2021
A Randomized Trial of Physical Activity in Children and Adolescents with CancerPaul Saultier, Clothilde Vallet, Frédéric Sotteau, et al.
Translational Oncology|August 2, 2011
Moving forward with metronomic chemotherapy: meeting report of the 2nd International Workshop on Metronomic and Anti-Angiogenic Chemotherapy in Paediatric OncologyEddy Pasquier, Mark W Kieran, Jaroslav Sterba, et al.
Cancer Causes & Control : CCC|March 8, 2020
Maternal and perinatal characteristics, congenital malformations and the risk of wilms tumor: the ESTELLE studyHélène Bauer, Paula Rios, Gudrun Schleiermacher, et al.
Frontiers in Pharmacology|October 16, 2018
Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical TrialArnauld Verschuur, Marie-Amélie Heng-Maillard, Philippe Dory-Lautrec, et al.
Pediatric Blood & Cancer|November 19, 2019
Exploring heterogeneity of adrenal cortical tumors in children: The French pediatric rare tumor group (Fracture) experienceCécile Picard, Cécile Faure-Conter, Pierre Leblond, et al.
Nature Communications|November 30, 2023
Delineating the interplay between oncogenic pathways and immunity in anaplastic Wilms tumorsXiaoping Su, Xiaofan Lu, Sehrish Khan Bazai, et al.
Pediatric Blood & Cancer|October 28, 2017
Irinotecan for relapsed Wilms tumor in pediatric patients: SIOP experience and review of the literature-A report from the SIOP Renal Tumor Study GroupJanna A Hol, Marry M van den Heuvel-Eibrink, Norbert Graf, et al.
The Lancet. Oncology|July 2, 2018
Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol databaseJesper Brok, Marta Lopez-Yurda, Harm V Tinteren, et al.
Pageof 6